These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34659112)

  • 1. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
    Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
    Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L; Marijic Buljubasic A; Budoff MJ; Copeland LA; Jackson NJ; Jasuja GK; Gornbein J; Reue K
    JAMA Netw Open; 2024 Jul; 7(7):e2419696. PubMed ID: 38954413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy.
    Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
    Eur J Prev Cardiol; 2022 Nov; 29(15):2017-2026. PubMed ID: 35778824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ; Cheung AS
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation.
    Nikzad N; Fisher AR; Pillai A; Targownik LE; Te HS; Aronsohn A; Paul S
    Am J Transplant; 2024 Sep; 24(9):1567-1572. PubMed ID: 38729612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK; Mullins ES
    J Thromb Haemost; 2024 Aug; 22(8):2129-2139. PubMed ID: 38795871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and cardiovascular risks of hormone treatment for transgender individuals.
    de Silva NL; Dimakopoulou A; Quinton O; Jayasena CN
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101907. PubMed ID: 38942618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
    Dix C; Moloney M; Tran HA; McFadyen JD
    Thromb Haemost; 2024 May; 124(5):387-398. PubMed ID: 37816389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgender patients and gender-affirming hormone therapy through the mid-life.
    Mehta JM; Kanell S; Borowicz CEA; Fisher MA
    Maturitas; 2024 Nov; 189():108093. PubMed ID: 39178607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.